(-0.58%) 5 022.21 points
(-0.12%) 37 753 points
(-1.15%) 15 683 points
(0.17%) $82.83
(1.81%) $1.743
(-0.03%) $2 387.60
(0.07%) $28.42
(-0.39%) $950.50
(-0.05%) $0.936
(-0.12%) $10.98
(-0.09%) $0.802
(0.00%) $94.06
Live Chart Being Loaded With Signals
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products...
Stats | |
---|---|
Today's Volume | 556 000 |
Average Volume | 4.20M |
Market Cap | 17.39B |
EPS | HKD0 ( 2024-03-26 ) |
Last Dividend | HKD0.131 ( 2023-09-14 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 5.94 |
ATR14 | HKD0.0190 (0.20%) |
Volume Correlation
United Laboratories Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
United Laboratories Correlation - Currency/Commodity
United Laboratories Financials
Annual | 2022 |
Revenue: | HKD11.33B |
Gross Profit: | HKD4.97B (43.84 %) |
EPS: | HKD0.870 |
Q2 | 2023 |
Revenue: | HKD6.91B |
Gross Profit: | HKD3.21B (46.53 %) |
EPS: | HKD0.710 |
Q4 | 2022 |
Revenue: | HKD6.15B |
Gross Profit: | HKD2.72B (44.13 %) |
EPS: | HKD0.520 |
Q2 | 2022 |
Revenue: | HKD5.18B |
Gross Profit: | HKD2.25B (43.50 %) |
EPS: | HKD0.350 |
Financial Reports:
No articles found.
United Laboratories Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0801 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.196 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.156 | 2008-05-26 |
Last Dividend | HKD0.131 | 2023-09-14 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 15 | -- |
Total Paid Out | HKD1.398 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.02 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.19 | |
Div. Directional Score | 8.91 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9908.HK | Ex Dividend Knight | 2023-09-18 | Annually | 0 | 0.00% | |
2166.HK | Ex Dividend Knight | 2023-06-05 | Semi-Annually | 0 | 0.00% | |
1177.HK | Ex Dividend Knight | 2023-10-04 | Semi-Annually | 0 | 0.00% | |
0255.HK | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
3866.HK | Ex Dividend Junior | 2023-06-02 | Annually | 0 | 0.00% | |
1739.HK | No Dividend Player | 2023-09-05 | Sporadic | 0 | 0.00% | |
0788.HK | Ex Dividend Junior | 2023-05-16 | Annually | 0 | 0.00% | |
2328.HK | Ex Dividend Knight | 2023-06-26 | Annually | 0 | 0.00% | |
1310.HK | Ex Dividend Junior | 2023-05-16 | Semi-Annually | 0 | 0.00% | |
0371.HK | Ex Dividend Junior | 2023-06-12 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.171 | 1.500 | 6.58 | 9.86 | [0 - 0.5] |
returnOnAssetsTTM | 0.113 | 1.200 | 6.23 | 7.48 | [0 - 0.3] |
returnOnEquityTTM | 0.202 | 1.500 | 8.87 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.122 | -1.000 | 8.78 | -8.78 | [0 - 1] |
currentRatioTTM | 1.870 | 0.800 | 5.65 | 4.52 | [1 - 3] |
quickRatioTTM | 1.387 | 0.800 | 6.54 | 5.24 | [0.8 - 2.5] |
cashRatioTTM | 0.672 | 1.500 | 7.38 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0771 | -1.500 | 8.72 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.414 | 2.00 | 9.53 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.901 | 2.00 | 9.55 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.132 | -1.500 | 9.47 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.454 | 1.000 | 5.77 | 5.77 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.204 | 1.000 | 7.92 | 7.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.685 | 1.000 | 1.749 | 1.749 | [0.2 - 2] |
assetTurnoverTTM | 0.661 | 0.800 | 8.93 | 7.14 | [0.5 - 2] |
Total Score | 11.63 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.37 | 1.000 | 9.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.202 | 2.50 | 9.27 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.901 | 2.00 | 9.70 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.16 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.414 | 2.00 | 9.53 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.122 | 1.500 | 8.78 | -8.78 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.197 | 1.000 | 7.58 | 0 | [0.1 - 0.5] |
Total Score | 6.19 |
United Laboratories
The United Laboratories International Holdings Limited, an investment holding company, engages in the research, development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, nervous system drugs, vitamins, and vacant gelatin capsules, as well as API and intermediate products. It also manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products. In addition, the company provides management services. It has operations in the People's Republic of China, Europe, India, the Middle East, South America, other Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators